Esperion Therapeutics Stock Options
| ESPR Stock | USD 1.87 0.03 1.63% |
Esperion Therapeutics' option chain provides insight into all available option contracts written on Esperion Therapeutics' stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Esperion Therapeutics' stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Esperion option contract.
In The Money vs. Out of Money Option Contracts on Esperion Therapeutics
Analyzing Esperion Therapeutics' in-the-money options over time can help investors to take a profitable long position in Esperion Therapeutics regardless of its overall volatility. This is especially true when Esperion Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Esperion Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Esperion Therapeutics' stock while costing only a fraction of its price.
Esperion Therapeutics' latest option contracts expiring on 2024-04-19 are carrying combined implied volatility of 409.35 with a put-to-call open interest ratio of 0.33 over 26 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2024-04-19. The current put volume is at 1112, with calls trading at the volume of 45. This yields a 24.71 put-to-call volume ratio. The Esperion Therapeutics option chain provides detailed quote and price information for the current Esperion Therapeutics option contracts. It shows all of Esperion Therapeutics' listed puts, calls, expiration dates, strike prices, and other pricing information.
Open Interest Against 2024-04-19 Option Contracts
Esperion Therapeutics option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Esperion Therapeutics' lending market. For example, when Esperion Therapeutics' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Esperion Therapeutics, he or she must hedge the risk by shorting Esperion Therapeutics stock over its option's life.
2024-04-19
The chart above shows Esperion Therapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Esperion Therapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Esperion Therapeutics' option, there is no secondary market available for investors to trade.
Esperion Therapeutics' stock options are financial instruments that give investors the right to buy or sell shares of Esperion Therapeutics common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell Esperion stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If Esperion Therapeutics' stock price goes up or down, the stock options follow.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Esperion Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. Please note that buying 'in-the-money' options on Esperion Therapeutics lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Esperion Therapeutics' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Esperion Therapeutics contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Esperion Stock moves the wrong way.
At this time, Esperion Therapeutics' Common Stock Total Equity is relatively stable compared to the past year. As of 04/19/2024, Common Stock Shares Outstanding is likely to grow to about 108.3 M, though Treasury Stock is likely to grow to (47 M). Esperion Therapeutics In The Money Call Balance
When Esperion Therapeutics' strike price is surpassing the current stock price, the option contract against Esperion Therapeutics stock is said to be in the money. When it comes to buying Esperion Therapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Esperion Therapeutics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Esperion Current Options Market Mood
Esperion Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Esperion Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of Esperion Therapeutics' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Esperion Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Esperion Therapeutics' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current Esperion contract
Base on the Rule 16, the options market is currently suggesting that Esperion Therapeutics will have an average daily up or down price movement of about 25.58% per day over the life of the 2024-04-19 option contract. With Esperion Therapeutics trading at USD 1.87, that is roughly USD 0.48. If you think that the market is fully incorporating Esperion Therapeutics' daily price movement you should consider buying Esperion Therapeutics options at the current volatility level of 409.35%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Esperion |
Purchasing Esperion Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Esperion calls. Remember, the seller must deliver Esperion Therapeutics stock to the call owner when a call is exercised.
Esperion Therapeutics Option Chain
When Esperion Therapeutics' strike price is surpassing the current stock price, the option contract against Esperion Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Esperion Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Esperion. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Esperion. It also shows strike prices and maturity days for a Esperion Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-04-19 CALL at $1.0 | 0.9148 | 0.144 | 0 | 2024-04-19 | 0.65 - 1.2 | 1.75 | In |
Call | 2024-04-19 CALL at $1.5 | 0.8001 | 0.4611 | 81 | 2024-04-19 | 0.3 - 0.55 | 0.45 | In |
Call | 2024-04-19 CALL at $2.0 | 0.3297 | 1.4634 | 695 | 2024-04-19 | 0.0 - 0.05 | 0.05 | Out |
Call | 2024-04-19 CALL at $2.5 | 0.1426 | 0.4943 | 3253 | 2024-04-19 | 0.0 - 0.05 | 0.03 | Out |
Put | 2024-04-19 PUT at $2.0 | -0.6311 | 1.2491 | 3176 | 2024-04-19 | 0.1 - 0.2 | 0.1 | In |
Put | 2024-04-19 PUT at $2.5 | -0.8883 | 0.4649 | 1045 | 2024-04-19 | 0.6 - 0.8 | 0.65 | In |
Put | 2024-04-19 PUT at $3.0 | -0.9143 | 0.2699 | 501 | 2024-04-19 | 1.05 - 1.2 | 1.15 | In |
Put | 2024-04-19 PUT at $3.5 | -0.7952 | 0.2684 | 0 | 2024-04-19 | 1.45 - 2.0 | 0.65 | In |
Put | 2024-04-19 PUT at $4.0 | -0.8097 | 0.2283 | 0 | 2024-04-19 | 1.95 - 2.5 | 1.42 | In |
Put | 2024-04-19 PUT at $4.5 | -0.8198 | 0.2019 | 0 | 2024-04-19 | 2.45 - 3.0 | 0.0 | In |
Esperion Therapeutics Total Stockholder Equity Over Time
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Total Stockholder Equity |
| Timeline |
Esperion Therapeutics Common Stock Total Equity Over Time
The total value of common stock equity held by shareholders, representing their ownership interest in the company. Common Stock Total Equity |
| Timeline |
Esperion Total Stockholder Equity
Total Stockholder Equity |
|
Be your own money manager
Our tools can tell you how much better you can do entering a position in Esperion Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Balance Of Power Now
Balance Of PowerCheck stock momentum by analyzing Balance Of Power indicator and other technical ratios |
| All Next | Launch Module |
Esperion Therapeutics Corporate Directors
Esperion Therapeutics corporate directors refer to members of an Esperion Therapeutics board of directors. The board of directors generally takes responsibility for the Esperion Therapeutics' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Esperion Therapeutics' board members must vote for the resolution. The Esperion Therapeutics board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Tracy Woody | Director | Profile | |
| Dov Goldstein | Independent Director | Profile | |
| Daniel Janney | Independent Director | Profile | |
| Nicole Vitullo | Director | Profile |
Already Invested in Esperion Therapeutics?
The danger of trading Esperion Therapeutics is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Esperion Therapeutics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Esperion Therapeutics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Esperion Therapeutics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Esperion Therapeutics is a strong investment it is important to analyze Esperion Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Esperion Therapeutics' future performance. For an informed investment choice regarding Esperion Stock, refer to the following important reports: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Esperion Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in Esperion Stock, please use our How to Invest in Esperion Therapeutics guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Esperion Stock analysis
When running Esperion Therapeutics' price analysis, check to measure Esperion Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Esperion Therapeutics is operating at the current time. Most of Esperion Therapeutics' value examination focuses on studying past and present price action to predict the probability of Esperion Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Esperion Therapeutics' price. Additionally, you may evaluate how the addition of Esperion Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |
Is Esperion Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Esperion Therapeutics. If investors know Esperion will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Esperion Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.03) | Revenue Per Share 1.128 | Quarterly Revenue Growth 0.714 | Return On Assets (0.43) | Return On Equity (2.61) |
The market value of Esperion Therapeutics is measured differently than its book value, which is the value of Esperion that is recorded on the company's balance sheet. Investors also form their own opinion of Esperion Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Esperion Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Esperion Therapeutics' market value can be influenced by many factors that don't directly affect Esperion Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Esperion Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Esperion Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Esperion Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.